Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: a National Cancer Institute of Canada Clinical Trials Group study.

Source:http://linkedlifedata.com/resource/pubmed/id/9626225

Download in:

View as

General Info

PMID
9626225